Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

147.68 -1.88 (-1.26%)
Streaming Delayed Price Updated: 10:28 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
Via AB Newswire
Exposures COVID-19
aCommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-commerce Future in the Philippines
Via ACN Newswire
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),... 
Via SBWire
OrPro Therapeutics Receives $2.147M Therapeutic Development Funding from US Department of Defense for COVID-19 and Influenza
Prestigious CDMRP award will advance development of ORP100S as an inhaled treatment for acute and chronic respiratory diseasesSAN DIEGO - July 19, 2022 - PRLog -- OrPro Therapeutics, Inc., a San Diego... 
Via PRLog
Topics Derivatives
Exposures COVID-19 Derivatives Product Safety
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters. 
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
Agilis is looking forward to continued growth with Denise as the Principal Consultant to help clients achieve their regulatory goals and create safer medical products for the end users. 
Via Newswire.com
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via Investor Brand Network
Exposures Product Safety
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill... 
Via FinancialNewsMedia
Exposures Product Safety
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Church & Dwight (NYSE: CHD) might not exactly be a household name, but you've likely heard of many of the company's brands: ARM & HAMMER, Trojan, First Response, Nair, Spinbrush, OxiClean, Orajel,... 
Via MarketBeat
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could... 
Via FinancialNewsMedia
Exposures COVID-19 Product Safety
MarketBeat: Week in Review 7/18 – 7/22
Investors should be careful not to read too much into this week's rally. Next week will bring the Fed's decision on interest rates and key earnings reports from the tech sector. Both could cause... 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates Supply Chain
Vaccines Market Expected to Witness a Sustainable Growth by 2032 - Future Market Insights, Inc.
FMI predicts vaccines market to reach a valuation of US $120B by 2032. Key Players - Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson &... 
Via Newswire.com
Exposures COVID-19
Healthcare Education Solutions Market Analysis, Size, Share, Trends, Global Industry Overview, Demand, Growth and Forecast 2028 Zimmer Biomet, Stryker, Medtronic, Canon Medical, Johnson & Johnson, FUJIFILM Holding, Olympus
Healthcare Education Solutions Market 2022 Industry Size, Share, Global Analysis, Growth, Development Status, Regional Trends, Opportunity Assessment and Comprehensive Research Study Forecast with... 
Via SBWire
Exposures COVID-19
Johnson & Johnson Reports Q2 2022 Results
From Johnson & Johnson
Via Business Wire
Is it Time to Cash Out Novavax Stock?
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. 
Via MarketBeat
Exposures COVID-19 Product Safety
Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Continues to Prove its Value in a Volatile Year
Johnson & Johnson is scheduled to release its second quarter earnings report on July 19, 2022. Low single-digit growth may not do much to excite investors. But in this article, we’ll take a closer look... 
Via MarketBeat
Topics Economy
Exposures Economy
Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
Global Cough Remedies Market Research 2022-2031 published by Calibre Research studies the current situation, Cough Remedies market size, share, trends, regional growth and the latest technologies... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Global Bio Implant Market 2022 Segment, Key Players Analysis and Forecast : Johnson & Johnson, Philips, Medtronic, C.R. Bard
Global Bio Implant Market Research 2022-2031 published by Calibre Research studies the current situation, Bio Implant market size, share, trends, regional growth and the latest technologies utilized by... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Global Human Papillomavirus Vaccine Market 2022 Manufacturers Review, Status and Forecast 2029 : Merck, GlaxoSmithKline, Sanofi, AstraZeneca
Global Human Papillomavirus Vaccine Market Research 2022-2031 published by Calibre Research studies the current situation, Human Papillomavirus Vaccine market size, share, trends, regional growth and... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
Global Tigecycline Market Research 2022-2031 published by Calibre Research studies the current situation, Tigecycline market size, share, trends, regional growth and the latest technologies utilized by... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Global Medical Box Market 2022: Latest Global Research Report and Analysis by Regions 2029 : 3M, Johnson & Johnson, Acme United, ZEE, Certified Safety
The research study on the global Medical Box market is a blend of informative statistics, quantitative & quantitative evaluation that has been offered by industry specialists, and key participants... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis... 
Via iCrowdNewswire
Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments
SOURCE: Johnson & Johnson 
Via 3BL Media
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.